Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Novopharm Biotech issued U.S. patent for two human monoclonal antibodies

June 27, 1997

Lidak reports promising phase I/II data with melanoma vaccine

June 27, 1997

Phase I studies reported for P&U fusion protein for GI malignancies

June 23, 1997

FDA advisory committee to review rituximab BLA

June 20, 1997

Novopharm Biotech files Canadian IND for hMAb

June 12, 1997

Cel-Sci receives approval to begin Multikine trial in Canada

June 11, 1997

Encouraging interim data from Avicidin trial

June 10, 1997

Immunex reports anticancer activity of Flt3 ligand

June 6, 1997

ImClone reaches milestone in small cell lung cancer treatment collaboration

June 6, 1997

Techniclone finalizes acquisition of Peregrine

June 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...